tradingkey.logo

DIH Holding US Inc

DHAI
查看詳細走勢圖
0.747USD
0.000
收盤 12/24, 13:00美東報價延遲15分鐘
1.26M總市值
虧損本益比TTM

DIH Holding US Inc

0.747
0.000
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

0.00%

1月

0.00%

6月

+238.42%

今年開始到現在

-45.88%

1年

-32.71%

查看詳細走勢圖

TradingKey DIH Holding US Inc股票評分

單位: USD 更新時間: 2025-11-06

操作建議

DIH Holding US Inc當前公司基本面數據相對謹慎,當前估值合理,機構持股佔比非常高,

DIH Holding US Inc評分

相關信息

行業排名
153 / 210
全市場排名
535 / 4615
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
--
目標均價
--
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

DIH Holding US Inc亮點

亮點風險
DIH Holding US, Inc. is a global provider of advanced robotic devices used in physical rehabilitation. Its rehabilitation hospitals and outpatient clinics offering solutions include ArmeoPower, ArmeoSpring, ArmeoSpring Pro, ArmeoSenso, Erigo, Lokomat, SafeGait 360 by Gorbel, RYSEN, Andago, C-Mill, and HocoNet. Its Research & Academia offering solutions include GRAIL, CAREN Extended, CAREN High-End, M-Gait, and D-Flow. The ArmeoSpring Pro is a cutting-edge medical device designed to bring upper limb rehabilitation to the next level. Its new arm weight support, powered by TrueG technology, allows patients to receive continuous arm weight support from shoulder extension to shoulder flexion. ArmeoPower guides the initial phases of arm and hand function recovery. ArmeoSpring supports the recovery of arm and hand functions. ArmeoSenso is a sensor-based solution for arm function recovery. HocoNet is a software platform connecting product portfolio across the entire continuum of care.
業績高增長
公司營業收入穩步增長,連續3年增長16.29%
業績增長期
公司處於發展階段,最新年度總收入62.86M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入62.86M美元
估值合理
公司最新PE估值-0.12,處於3年歷史合理位
機構減倉
最新機構持股152.84K股,環比減少60.40%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉50.13K股

DIH Holding US Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

DIH Holding US Inc簡介

DIH Holding US, Inc. is a global provider of advanced robotic devices used in physical rehabilitation. Its rehabilitation hospitals and outpatient clinics offering solutions include ArmeoPower, ArmeoSpring, ArmeoSpring Pro, ArmeoSenso, Erigo, Lokomat, SafeGait 360 by Gorbel, RYSEN, Andago, C-Mill, and HocoNet. Its Research & Academia offering solutions include GRAIL, CAREN Extended, CAREN High-End, M-Gait, and D-Flow. The ArmeoSpring Pro is a cutting-edge medical device designed to bring upper limb rehabilitation to the next level. Its new arm weight support, powered by TrueG technology, allows patients to receive continuous arm weight support from shoulder extension to shoulder flexion. ArmeoPower guides the initial phases of arm and hand function recovery. ArmeoSpring supports the recovery of arm and hand functions. ArmeoSenso is a sensor-based solution for arm function recovery. HocoNet is a software platform connecting product portfolio across the entire continuum of care.
公司代碼DHAI
公司DIH Holding US Inc
CEOMr. Jason Chen
網址https://www.dih.com/

常見問題

DIH Holding US Inc(DHAI)的當前股價是多少?

DIH Holding US Inc(DHAI)的當前股價是 0.747。

DIH Holding US Inc 的股票代碼是什麼?

DIH Holding US Inc的股票代碼是DHAI。

DIH Holding US Inc股票的52週最高點是多少?

DIH Holding US Inc股票的52週最高點是73.250。

DIH Holding US Inc股票的52週最低點是多少?

DIH Holding US Inc股票的52週最低點是0.660。

DIH Holding US Inc的市值是多少?

DIH Holding US Inc的市值是1.26M。

DIH Holding US Inc的淨利潤是多少?

DIH Holding US Inc的淨利潤為-8.68M。

現在DIH Holding US Inc(DHAI)的股票是買入、持有還是賣出?

根據分析師評級,DIH Holding US Inc(DHAI)的總體評級為--,目標價格為--。

DIH Holding US Inc(DHAI)股票的每股收益(EPS TTM)是多少

DIH Holding US Inc(DHAI)股票的每股收益(EPS TTM)是-6.066。
KeyAI